Standards of care for patients with malignant melanoma.
Dunn
C L
CL
Zitelli
J A
JA
D000970:Antineoplastic Agents / Q000627:therapeutic use; D001706:Biopsy / Q000379:methods; D006801:Humans; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000627:therapeutic use; D008197:Lymph Node Excision; D008198:Lymph Nodes / Q000473:pathology*; D008545:Melanoma / Q000188:drug therapy / Q000401:mortality / Q000473:pathology* / Q000601:surgery; D011994:Recombinant Proteins; D020133:Reverse Transcriptase Polymerase Chain Reaction; D016019:Survival Analysis
D000970:Antineoplastic Agents; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins